JP2024517942A - Gタンパク質共役受容体の調節剤 - Google Patents
Gタンパク質共役受容体の調節剤 Download PDFInfo
- Publication number
- JP2024517942A JP2024517942A JP2023569936A JP2023569936A JP2024517942A JP 2024517942 A JP2024517942 A JP 2024517942A JP 2023569936 A JP2023569936 A JP 2023569936A JP 2023569936 A JP2023569936 A JP 2023569936A JP 2024517942 A JP2024517942 A JP 2024517942A
- Authority
- JP
- Japan
- Prior art keywords
- compound
- group
- independently selected
- optionally substituted
- ring
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/605—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Holo Graphy (AREA)
- Gyroscopes (AREA)
- Amplifiers (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163188342P | 2021-05-13 | 2021-05-13 | |
| US63/188,342 | 2021-05-13 | ||
| PCT/US2022/029305 WO2022241287A2 (en) | 2021-05-13 | 2022-05-13 | Modulators of g-protein coupled receptors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024517942A true JP2024517942A (ja) | 2024-04-23 |
| JP2024517942A5 JP2024517942A5 (cg-RX-API-DMAC10.html) | 2025-05-22 |
Family
ID=82019613
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023569936A Pending JP2024517942A (ja) | 2021-05-13 | 2022-05-13 | Gタンパク質共役受容体の調節剤 |
Country Status (20)
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20240118914A (ko) | 2021-01-20 | 2024-08-05 | 바이킹 테라퓨틱스 인코포레이티드 | 대사 및 간 질환 치료를 위한 조성물 및 방법 |
| KR20240007251A (ko) * | 2021-05-13 | 2024-01-16 | 카모트 테라퓨틱스, 인크. | G-단백질 결합 수용체의 조절제 |
| CA3231953A1 (en) | 2021-09-15 | 2023-03-23 | Brian Lian | Compositions and methods for the treatment of metabolic and liver disorders |
| KR20250140132A (ko) * | 2023-01-18 | 2025-09-24 | 상하이 민웨이 바이오테크놀로지 씨오 엘티디 | 삼중 활성을 갖는 융합 단백질 및 그 용도 |
| EP4716545A1 (en) * | 2023-05-21 | 2026-04-01 | Carmot Therapeutics Inc. | Treatment of adults with overweight or obesity with or without weight-related comorbidities |
| EP4777197A2 (en) | 2023-09-14 | 2026-07-22 | Ascletis Pharma (China) Co., Limited | Glp-1r agonist and therapeutic method thereof |
| WO2025109387A1 (en) | 2023-11-24 | 2025-05-30 | Ascletis Pharma (China) Co., Limited | Glp-1r agonist and therapeutic method thereof |
| TW202600132A (zh) | 2024-03-08 | 2026-01-01 | 美商安尼波那生物公司 | 用於治療肥胖症及提高減重之方法 |
| WO2026030653A1 (en) | 2024-07-31 | 2026-02-05 | Carmot Therapeutics Inc. | Synthesis of an intermediate and its use for the preparation of glp-1r/gipr agonists |
| WO2026027650A1 (en) | 2024-08-02 | 2026-02-05 | F. Hoffmann-La Roche Ag | Process for the preparation of 2-(3-cyano-5-fluorophenyl)-2-methyl-propionic acid |
| TW202620036A (zh) | 2024-09-27 | 2026-05-16 | 美商卡默療法股份有限公司 | 肽酪胺酸-酪胺酸(pyy)類似物及glp-1r促效劑之組合療法 |
| WO2026092581A1 (en) | 2024-10-30 | 2026-05-07 | Ascletis Pharma (China) Co., Limited | Thyroid hormone receptor beta modulator alone or in combination with a modulator of glp-1r, gipr or gcgr, for use in the treatment of obesity or overweight or for treating alopecia areata |
| WO2026092580A1 (en) | 2024-10-30 | 2026-05-07 | Ascletis Pharma (China) Co., Limited | Glp-1r\gipr\gcgr modulator in combination with thr-beta modulator for treatment of metabolic diseases |
| WO2026099325A1 (en) * | 2024-11-08 | 2026-05-15 | F. Hoffmann-La Roche Ag | X-β-ALA-GLU(OTBU)-GLY TETRAMER AND ITS USE IN SPPS SYNTHESIS |
| WO2026112366A1 (en) * | 2024-11-20 | 2026-05-28 | Carmot Therapeutics Inc. | Treatment of steatotic liver disease associated with metabolic dysfunction |
| WO2026119942A1 (en) * | 2024-12-05 | 2026-06-11 | F. Hoffmann-La Roche Ag | Synthesis of a peptide including stepwise sidechain preparation |
| WO2026119946A1 (en) * | 2024-12-05 | 2026-06-11 | F. Hoffmann-La Roche Ag | Spps synthesis of a peptide with bsmoc-lys building block |
| WO2026119941A1 (en) * | 2024-12-05 | 2026-06-11 | F. Hoffmann-La Roche Ag | Spps synthesis of a peptide comprising a fatty acid side chain |
| WO2026125207A1 (en) * | 2024-12-09 | 2026-06-18 | F. Hoffmann-La Roche Ag | Process for the preparation of a x-beta-ala-glu(otbu)-gly tetramer by lpps and its use in spps synthesis |
| WO2026131797A2 (en) | 2024-12-18 | 2026-06-25 | F. Hoffmann-La Roche Ag | Process for the preparation of a fatty acid compound |
| WO2026153900A1 (en) | 2025-01-15 | 2026-07-23 | F. Hoffmann-La Roche Ag | Process for the preparation of a bsmoc-lys fatty acid compound |
| CN119930843B (zh) * | 2025-01-22 | 2025-12-30 | 北京康乐卫士生物技术股份有限公司 | 具有glp和gip双重活性的融合蛋白及其应用 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2017534676A (ja) * | 2014-09-24 | 2017-11-24 | インディアナ ユニヴァーシティ リサーチ アンド テクノロジー コーポレイション | インクレチン−インスリンコンジュゲート |
| WO2019183577A1 (en) * | 2018-03-23 | 2019-09-26 | Carmot Therapeutics, Inc. | Modulators of g-protein coupled receptors |
Family Cites Families (73)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1072649C (zh) | 1995-09-13 | 2001-10-10 | 武田药品工业株式会社 | 苯并氧杂吖庚因化合物,其生产方法和用途 |
| US6432947B1 (en) | 1997-02-19 | 2002-08-13 | Berlex Laboratories, Inc. | N-heterocyclic derivatives as NOS inhibitors |
| AU2610899A (en) | 1998-02-27 | 1999-09-15 | Novo Nordisk A/S | N-terminally modified glp-1 derivatives |
| EP1137667B1 (en) | 1998-12-07 | 2004-11-17 | Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. | Analogues of glp-1 |
| CN1364167A (zh) | 1999-02-26 | 2002-08-14 | 阿瑞那制药公司 | G蛋白偶联受体6的小分子调节剂 |
| AR035016A1 (es) | 1999-08-25 | 2004-04-14 | Takeda Chemical Industries Ltd | Composicion de azol promotor de produccion/secrecion de neurotrofina, compuesto prodroga del mismo, composicion farmaceutica que lo comprende y uso del mismo para preparar esta ultima. |
| EP1235618A2 (en) | 1999-09-07 | 2002-09-04 | Conjuchem, Inc. | Bioconjugation in vivo to pulmonary or blood components |
| EP1302462A4 (en) | 2000-07-17 | 2007-07-18 | Takeda Pharmaceutical | SULFONATE DERIVATIVES, PROCESS FOR PRODUCTION AND USE THEREOF |
| BR0315815A (pt) | 2002-11-01 | 2005-09-13 | Takeda Pharmaceutical | Agentes para prevenir ou tratar neuropatia, para promover a produção ou a secreção de um fator neurotrópico, para melhorar a dor, neuroprotetor e farmacêutico, composto, métodos para prevenir ou tratar neuropatia e para promover a produção ou a secreção de um fator neurotrópico, para melhorar a dor para proteger um nervo em um mamìfero e para produzir um composto e uso de um composto |
| AU2003277576A1 (en) | 2002-11-08 | 2004-06-07 | Takeda Pharmaceutical Company Limited | Receptor function controlling agent |
| US20070004736A1 (en) | 2002-11-22 | 2007-01-04 | Keiji Kubo | Imidazole derivative, process for producing the same, and use |
| WO2004067548A2 (en) | 2003-01-31 | 2004-08-12 | Theratechnologies Inc. | Chemically modified metabolites of regulatory peptides and methods of producing and using same |
| US7820837B2 (en) | 2003-05-30 | 2010-10-26 | Takeda Pharmaceutical Company Limited | Condensed ring compound |
| EP1670515A2 (en) | 2003-09-19 | 2006-06-21 | Novo Nordisk A/S | Albumin-binding derivatives of therapeutic peptides |
| EP1669352A4 (en) | 2003-09-30 | 2008-12-17 | Takeda Pharmaceutical | THIAZOLINE DERIVATIVE AND ITS USE |
| GB0325644D0 (en) | 2003-11-04 | 2003-12-10 | Avidex Ltd | Immuno ihibitory pyrazolone compounds |
| WO2005058823A1 (ja) | 2003-12-17 | 2005-06-30 | Takeda Pharmaceutical Company Limited | ウレア誘導体、その製造法及び用途 |
| US7456218B2 (en) | 2003-12-25 | 2008-11-25 | Takeda Pharmaceutical Company Limited | 3-(4-benzyloxyphenyl) propanoic acid derivatives |
| WO2005063725A1 (ja) | 2003-12-26 | 2005-07-14 | Takeda Pharmaceutical Company Limited | フェニルプロパン酸誘導体 |
| WO2005087710A1 (ja) | 2004-03-15 | 2005-09-22 | Takeda Pharmaceutical Company Limited | アミノフェニルプロパン酸誘導体 |
| JP4859665B2 (ja) | 2004-03-30 | 2012-01-25 | 武田薬品工業株式会社 | アルコキシフェニルプロパン酸誘導体 |
| TWI396686B (zh) | 2004-05-21 | 2013-05-21 | Takeda Pharmaceutical | 環狀醯胺衍生物、以及其製品和用法 |
| US20060275288A1 (en) | 2005-01-20 | 2006-12-07 | Grihalde Nelson D | GLP-1 receptor agonist and allosteric modulator monoclonal antibodies and uses thereof |
| US8957070B2 (en) | 2005-04-20 | 2015-02-17 | Takeda Pharmaceutical Company Limited | Glucokinase activator compounds, methods of activating glucokinase and methods of treating diabetes and obesity |
| CA2607566A1 (en) | 2005-05-06 | 2006-11-16 | Bayer Pharmaceuticals Corporation | Glucagon-like peptide 1 (glp-1) receptor agonists and their pharmacological methods of use |
| EP1916234B1 (en) | 2005-07-29 | 2014-11-12 | Takeda Pharmaceutical Company Limited | Cyclopropanecarboxylic acid compound |
| US20090054435A1 (en) | 2005-07-29 | 2009-02-26 | Hiroshi Imoto | Phenoxyalkanoic Acid Compound |
| JP4094660B1 (ja) | 2005-08-10 | 2008-06-04 | 武田薬品工業株式会社 | 糖尿病治療剤 |
| JP2007063225A (ja) | 2005-09-01 | 2007-03-15 | Takeda Chem Ind Ltd | イミダゾピリジン化合物 |
| PE20071221A1 (es) | 2006-04-11 | 2007-12-14 | Arena Pharm Inc | Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas |
| AU2007265966B2 (en) | 2006-06-27 | 2012-05-17 | Takeda Pharmaceutical Company Limited | Fused cyclic compounds |
| JP5399244B2 (ja) | 2006-08-17 | 2014-01-29 | アミリン・ファーマシューティカルズ,リミテッド・ライアビリティ・カンパニー | 選択可能な特性を持つdpp−iv耐性gipハイブリッドポリペプチド |
| EP2298772A1 (en) | 2006-10-18 | 2011-03-23 | Takeda Pharmaceutical Company Limited | Fused heterocyclic compounds |
| CN101573357B (zh) | 2006-10-19 | 2013-01-23 | 武田药品工业株式会社 | 吲哚化合物 |
| WO2008093639A1 (ja) | 2007-01-29 | 2008-08-07 | Takeda Pharmaceutical Company Limited | ピラゾール化合物 |
| AU2008215490A1 (en) | 2007-02-09 | 2008-08-21 | Takeda Pharmaceutical Company Limited | Fused ring compounds as partial agonists of PPAR-gamma |
| JPWO2008136428A1 (ja) | 2007-04-27 | 2010-07-29 | 武田薬品工業株式会社 | 含窒素5員複素環化合物 |
| EP2157859A4 (en) | 2007-06-19 | 2011-01-12 | Takeda Pharmaceutical | INDAZOL COMPOUNDS FOR THE ACTIVATION OF GLUCCOKINASE |
| HUE032284T2 (en) | 2008-03-18 | 2017-09-28 | Novo Nordisk As | Protease-stabilized, acylated insulin analogues |
| ES2558842T3 (es) | 2008-06-17 | 2016-02-09 | Indiana University Research And Technology Corporation | Agonistas mixtos a base de GIP para el tratamiento de trastornos metabólicos y obesidad |
| TW201006821A (en) | 2008-07-16 | 2010-02-16 | Bristol Myers Squibb Co | Pyridone and pyridazone analogues as GPR119 modulators |
| US20120148586A1 (en) | 2009-08-27 | 2012-06-14 | Joyce Ching Tsu Chou | Glucagon-like protein-1 receptor (glp-1r) agonists for treating autoimmune disorders |
| US8426414B2 (en) | 2009-10-09 | 2013-04-23 | Bristol-Myers Squibb Company | Modulators of G protein-coupled receptor 88 |
| KR20120123443A (ko) | 2010-01-27 | 2012-11-08 | 인디애나 유니버시티 리서치 앤드 테크놀로지 코퍼레이션 | 대사 장애 및 비만 치료용 글루카곤 길항제-gip 항진제 콘쥬게이트 |
| CN103221404B (zh) | 2010-05-13 | 2015-12-16 | 安姆根有限公司 | 可用作pde10抑制剂的不饱和氮杂环化合物 |
| US20120021979A1 (en) | 2010-06-24 | 2012-01-26 | Vanderbilt University | GLP-1 receptor modulation of addiction, neuropsychiatric disorders and erectile dysfunction |
| RU2013133803A (ru) | 2010-12-22 | 2015-01-27 | Маркадиа Байотек, Инк. | Способы лечения метаболических нарушений и ожирения при помощи пептидов на основе глюкагона, активных по отношению к рецепторам гип и гпп |
| CA3134906A1 (en) | 2011-05-18 | 2012-11-22 | Mederis Diabetes, Llc | Improved peptide pharmaceuticals for insulin resistance |
| KR102002783B1 (ko) | 2011-06-10 | 2019-07-24 | 베이징 한미 파마슈티컬 컴퍼니 리미티드 | 포도당 의존성 인슐리노트로핀 폴리펩타이드 유사물질, 이의 약학적 조성물 및 응용 |
| US20150087586A1 (en) | 2012-03-29 | 2015-03-26 | Cebix, Inc. | Pegylated c-peptide |
| CN104884056A (zh) | 2012-11-12 | 2015-09-02 | 雷德伍德生物科技股份有限公司 | 用于制备缀合物的化合物和方法 |
| JP6548579B2 (ja) | 2012-12-06 | 2019-07-24 | ヴィクトリア リンク リミテッド | コンジュゲート化合物 |
| US9766239B2 (en) | 2013-03-13 | 2017-09-19 | Arizona Board Of Regents On Behalf Of Arizona State University | Synbodies for detection of human norovirus |
| CN105555756B (zh) | 2013-06-28 | 2018-12-07 | 奥克兰联合服务有限公司 | 氨基酸缀合物和肽缀合物及缀合方法 |
| WO2015031268A1 (en) | 2013-08-26 | 2015-03-05 | Arizona Board Of Regents On Behalf Of Arizona State University | High affinity synbodies for influenza |
| GB2528436A (en) | 2014-07-15 | 2016-01-27 | Lancaster Univ Business Entpr Ltd | Treatment of neurological diseases |
| EP3218414A1 (en) | 2014-11-14 | 2017-09-20 | Angiochem Inc. | Conjugates including an antibody moiety, a polypeptide that traverses the blood-brain barrier, and a cytotoxin |
| AR103242A1 (es) | 2015-01-09 | 2017-04-26 | Lilly Co Eli | Compuestos co-agonistas de gip y glp-1 |
| WO2016131893A1 (en) | 2015-02-18 | 2016-08-25 | Medimmune Limited | Incretin fusion polypeptides |
| TWI622596B (zh) | 2015-10-26 | 2018-05-01 | 美國禮來大藥廠 | 升糖素受體促效劑 |
| GB2551945B (en) | 2015-12-18 | 2021-09-08 | Heptares Therapeutics Ltd | Novel GLP-1 receptor agonist peptides |
| GB201620611D0 (en) | 2016-12-05 | 2017-01-18 | Univ Of Lancaster | Treatment of neurological diseases |
| TWI799680B (zh) | 2019-01-29 | 2023-04-21 | 美商美國禮來大藥廠 | 製備gip/glp1雙重促效劑之方法 |
| CN110684082B (zh) | 2019-10-08 | 2021-12-10 | 江苏诺泰澳赛诺生物制药股份有限公司 | Gip和glp-1双激动多肽化合物及药学上可接受的盐与用途 |
| TW202216746A (zh) | 2020-06-22 | 2022-05-01 | 印度商太陽製藥工業有限公司 | 長效型glp-1/gip雙重促效劑 |
| KR20220050820A (ko) | 2020-10-16 | 2022-04-25 | 한미약품 주식회사 | Glp-1/gip 이중작용제, 이의 지속형 결합체, 및 이를 포함하는 약학적 조성물 |
| CN116171164A (zh) | 2020-10-17 | 2023-05-26 | 太阳医药工业有限公司 | Glp-1/gip双重激动剂 |
| CN114617956B (zh) | 2020-12-10 | 2023-10-03 | 江苏中新医药有限公司 | 一种高效降糖的蛋白质药物 |
| CN116635050A (zh) | 2020-12-24 | 2023-08-22 | 韩美药品株式会社 | 对胰高血糖素、glp-1和gip受体全部具有活性的新型三重激动剂及其用途 |
| KR20240007251A (ko) * | 2021-05-13 | 2024-01-16 | 카모트 테라퓨틱스, 인크. | G-단백질 결합 수용체의 조절제 |
| IL310644A (en) | 2021-08-23 | 2024-04-01 | Lilly Co Eli | Compounds and Methods for Liquid Phase Synthesis |
| EP4410827A4 (en) | 2021-09-02 | 2026-04-29 | Sunshine Lake Pharma Co Ltd | GLP-1/GIP Dual Target Fusion Polypeptide and Protein and Their Applications |
| EP4436991A1 (en) | 2021-11-22 | 2024-10-02 | Sun Pharmaceutical Industries Limited | Process for the preparation of tirzepatide or pharmaceutically acceptable salt thereof |
-
2022
- 2022-05-13 KR KR1020237042878A patent/KR20240007251A/ko active Pending
- 2022-05-13 MX MX2023013492A patent/MX2023013492A/es unknown
- 2022-05-13 IL IL308392A patent/IL308392A/en unknown
- 2022-05-13 EP EP22729907.0A patent/EP4337682A2/en active Pending
- 2022-05-13 PE PE2023003051A patent/PE20240890A1/es unknown
- 2022-05-13 AU AU2022272251A patent/AU2022272251A1/en active Pending
- 2022-05-13 CA CA3220005A patent/CA3220005A1/en active Pending
- 2022-05-13 US US17/744,540 patent/US12281149B2/en active Active
- 2022-05-13 JP JP2023569936A patent/JP2024517942A/ja active Pending
- 2022-05-13 GE GEAP202416419A patent/GEAP202416419A/en unknown
- 2022-05-13 CR CR20230530A patent/CR20230530A/es unknown
- 2022-05-13 CN CN202280048710.4A patent/CN117980325A/zh active Pending
- 2022-05-13 WO PCT/US2022/029305 patent/WO2022241287A2/en not_active Ceased
- 2022-05-13 BR BR112023023559A patent/BR112023023559A2/pt unknown
- 2022-05-13 TW TW111118138A patent/TW202313666A/zh unknown
-
2023
- 2023-11-09 DO DO2023000247A patent/DOP2023000247A/es unknown
- 2023-11-10 CL CL2023003369A patent/CL2023003369A1/es unknown
- 2023-11-13 JO JOJO/P/2023/0291A patent/JOP20230291A1/ar unknown
- 2023-11-21 CO CONC2023/0015805A patent/CO2023015805A2/es unknown
- 2023-12-13 EC ECSENADI202393673A patent/ECSP23093673A/es unknown
-
2024
- 2024-07-18 US US18/777,223 patent/US20240383960A1/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2017534676A (ja) * | 2014-09-24 | 2017-11-24 | インディアナ ユニヴァーシティ リサーチ アンド テクノロジー コーポレイション | インクレチン−インスリンコンジュゲート |
| WO2019183577A1 (en) * | 2018-03-23 | 2019-09-26 | Carmot Therapeutics, Inc. | Modulators of g-protein coupled receptors |
Non-Patent Citations (1)
| Title |
|---|
| "Genetic and biased agonist-mediated reductions in β-arrestin recruitment prolong cAMP signaling at", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. Volume 296, Article 100133, JPN6026008917, 4 January 2021 (2021-01-04), pages 1 - 15, ISSN: 0005810823 * |
Also Published As
| Publication number | Publication date |
|---|---|
| ECSP23093673A (es) | 2024-01-31 |
| GEAP202416419A (en) | 2024-03-25 |
| MX2023013492A (es) | 2024-02-29 |
| WO2022241287A2 (en) | 2022-11-17 |
| CA3220005A1 (en) | 2022-11-17 |
| BR112023023559A2 (pt) | 2024-02-06 |
| PE20240890A1 (es) | 2024-04-24 |
| US12281149B2 (en) | 2025-04-22 |
| EP4337682A2 (en) | 2024-03-20 |
| DOP2023000247A (es) | 2024-03-28 |
| WO2022241287A3 (en) | 2022-12-29 |
| CO2023015805A2 (es) | 2023-12-11 |
| CN117980325A (zh) | 2024-05-03 |
| AU2022272251A1 (en) | 2023-11-16 |
| CR20230530A (es) | 2024-02-19 |
| TW202313666A (zh) | 2023-04-01 |
| IL308392A (en) | 2024-01-01 |
| JOP20230291A1 (ar) | 2023-11-13 |
| US20240383960A1 (en) | 2024-11-21 |
| CL2023003369A1 (es) | 2024-05-17 |
| US20230151074A1 (en) | 2023-05-18 |
| KR20240007251A (ko) | 2024-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12281149B2 (en) | Modulators of G-protein coupled receptors | |
| TWI840348B (zh) | G蛋白偶聯受體調節劑 | |
| US12552791B2 (en) | Heterocyclic GLP-1 agonists | |
| JP2023513272A (ja) | ヘテロ環glp-1アゴニスト | |
| EP3105213B1 (en) | Dihydrobenzofuran compounds useful in the treatment of diabetes and obesity | |
| JP6380402B2 (ja) | ソマトスタチン受容体作動活性を有する化合物およびその医薬用途 | |
| EP4638440A1 (en) | Heterocyclic glp-1 agonists | |
| TW202506102A (zh) | 雜環的glp-1促效劑 | |
| KR20250157491A (ko) | Glp-1 효능제 활성을 갖는 화합물의 염 및 고체 형태 | |
| EA052579B1 (ru) | Модуляторы сопряженных с g-белком рецепторов | |
| EP3650440A1 (en) | Benzoic ester compound | |
| EA051684B1 (ru) | Модуляторы сопряженных с g-белком рецепторов | |
| HK40022717A (en) | Benzoic ester compound | |
| HK1227023B (en) | Dihydrobenzofuran compounds useful in the treatment of diabetes and obesity | |
| HK1227023A1 (en) | Dihydrobenzofuran compounds useful in the treatment of diabetes and obesity |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240926 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20241016 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250512 |
|
| A524 | Written submission of copy of amendment under article 19 pct |
Free format text: JAPANESE INTERMEDIATE CODE: A524 Effective date: 20250512 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20250512 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20260305 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20260603 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20260622 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20260729 |